Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1453]

Maintenance in NSCLC: Arguments for

Dr Jaishree Bhosle - The Royal Marsden NHS Foundation Trust, London, UK

Maintenance in NSCLC: Arguments for ( Dr Jaishree Bhosle - The Royal Marsden NHS Foundation Trust, London, UK )

Maintenance in NSCLC: Arguments against

Dr Benjamin Besse - Institut Gustave Roussy, Paris, France

Maintenance in NSCLC: Arguments against ( Dr Benjamin Besse - Institut Gustave Roussy, Paris, France )

Current standards of care in advanced NSCLC

Dr Frances Shepherd - The Princess Margaret Cancer Centre, Toronto, Canada

Current standards of care in advanced NSCLC ( Dr Frances Shepherd - The Princess Margaret Cancer Centre, Toronto, Canada )

Hope, hype, misinformation and clinical evidence

Prof Michael Brada - University of Liverpool, Liverpool, UK

Hope, hype, misinformation and clinical evidence ( Prof Michael Brada - University of Liverpool, Liverpool, UK )

Proton therapy in the UK: The Newport clinic

Dr Jamie Powell - Proton Partners International, Newport, UK

Proton therapy in the UK: The Newport clinic ( Dr Jamie Powell - Proton Partners International, Newport, UK )

Health economics in high-cost cancer

Prof Nick Bosanquet - Imperial College London, London, UK

Health economics in high-cost cancer ( Prof Nick Bosanquet - Imperial College London, London, UK )

When is an assay ready for the clinic?

Dr Erasmus Schneider - Wadsworth Center, Albany, USA

When is an assay ready for the clinic? ( Dr Erasmus Schneider - Wadsworth Center, Albany, USA )

Building a succesful proton therapy centre

Prof James Metz - University of Pennsylvania, Philadelphia, USA

Building a succesful proton therapy centre ( Prof James Metz - University of Pennsylvania, Philadelphia, USA )

Practical implementation of proton therapy in the UK

Prof Karol Sikora - Proton Partners International, Cardiff, UK

Practical implementation of proton therapy in the UK ( Prof Karol Sikora - Proton Partners International, Cardiff, UK )

The use of proton therapy in relatively new indications

Dr Jiří Kubeš - Proton Therapy Center Czech, Prague, Czech Republic

The use of proton therapy in relatively new indications ( Dr Jiří Kubeš - Proton Therapy Center Czech, Prague, Czech Republic )

A model-based selection approach to identify suitable indications for proton...

Prof Johannes Langendijk - University of Groningen, Groningen, Netherlands

A model-based selection approach to identify suitable indications for proton therapy ( Prof Johannes Langendijk - University of Groningen, Groningen, Netherlands )

Genomic characterisation and risk stratification of AML

Dr Moritz Gerstung - European Bioinformatics Institute, Hinxton, UK

Genomic characterisation and risk stratification of AML ( Dr Moritz Gerstung - European Bioinformatics Institute, Hinxton, UK )

More from ecancer